Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant)

Clinical trial NCT00903552 · COMPLETED

Trial details

NCT number: NCT00903552
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2009-05-01
Primary completion: 2009-10-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.